At Sarah Cannon, there has been a legacy of devotion to cancer research. Our team of collaborating SCRI sites have enrolled thousands of patients onto clinical trials.
By inhabiting the intersection where cutting-edge research meets compassionate care, we are redefining the standard for quality and excellence in oncology around the world.
Balancing science, care and commitment, Sarah Cannon is proud to promote partnership with community physicians and academic institutions.
NewsSee All News >>
May 3 HCA redefined community-based hospital care, and now it hopes to redefine world-class cancer care through its wholly owned subsidiary, Sarah Cannon.
Apr 29 A new genetic profiling laboratory that will pioneer a quick and cost-effective new tumour test will give doctors a better chance of identifying the right treatment for UK cancer patients and increase access to clinical trials for the latest therapies.
Apr 5 Sarah Cannon Research Institute (SCRI) principal investigators authored fourteen abstracts accepted for presentation at the American Association for Cancer Research Annual Meeting 2013, which runs from April 6-10 in Washington, D.C.
Feb 22 Exciting approval of an agent that SCRI led in development, from first dosing to registration.
A dedicated information service for our community of patients and partners.